Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

422 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Bosentan therapy in patients with Eisenmenger syndrome: a multicenter, double-blind, randomized, placebo-controlled study.
Galiè N, Beghetti M, Gatzoulis MA, Granton J, Berger RM, Lauer A, Chiossi E, Landzberg M; Bosentan Randomized Trial of Endothelin Antagonist Therapy-5 (BREATHE-5) Investigators. Galiè N, et al. Among authors: lauer a. Circulation. 2006 Jul 4;114(1):48-54. doi: 10.1161/CIRCULATIONAHA.106.630715. Epub 2006 Jun 26. Circulation. 2006. PMID: 16801459 Clinical Trial.
Atrial septal defects versus ventricular septal defects in BREATHE-5, a placebo-controlled study of pulmonary arterial hypertension related to Eisenmenger's syndrome: a subgroup analysis.
Berger RM, Beghetti M, Galiè N, Gatzoulis MA, Granton J, Lauer A, Chiossi E, Landzberg M. Berger RM, et al. Among authors: lauer a. Int J Cardiol. 2010 Oct 29;144(3):373-8. doi: 10.1016/j.ijcard.2009.04.037. Epub 2009 May 21. Int J Cardiol. 2010. PMID: 19464064 Clinical Trial.
Subretinal Gene Therapy Drug AGTC-501 for XLRP Phase 1/2 Multicenter Study (HORIZON): 24-Month Safety and Efficacy Results: Subretinal Gene Therapy AGTC-501 for XLRP Ph 1/2 24M Results.
Yang P, Birch D, Lauer A, Sisk R, Anand R, Pennesi ME, Iannaccone A, Yaghy A, Scaria A, Jung J, Curtiss D, Waheed NK. Yang P, et al. Among authors: lauer a. Am J Ophthalmol. 2024 Dec 4:S0002-9394(24)00552-X. doi: 10.1016/j.ajo.2024.11.021. Online ahead of print. Am J Ophthalmol. 2024. PMID: 39643074 Free article.
XOLARIS: A 24-Month, Prospective, Natural History Study of 201 Participants with Retinitis Pigmentosa GTPase Regulator-Associated X-Linked Retinitis Pigmentosa.
MacLaren RE, Duncan JL, Fischer MD, Lam BL, Meunier I, Pennesi ME, Sankila EK, Gow JA, Li J, Tsang SF; XOLARIS Study Group. MacLaren RE, et al. Ophthalmol Sci. 2024 Aug 13;5(1):100595. doi: 10.1016/j.xops.2024.100595. eCollection 2025 Jan-Feb. Ophthalmol Sci. 2024. PMID: 39493534 Free PMC article.
Bats as instructive animal models for studying longevity and aging.
Cooper LN, Ansari MY, Capshaw G, Galazyuk A, Lauer AM, Moss CF, Sears KE, Stewart M, Teeling EC, Wilkinson GS, Wilson RC, Zwaka TP, Orman R. Cooper LN, et al. Among authors: lauer am. Ann N Y Acad Sci. 2024 Nov;1541(1):10-23. doi: 10.1111/nyas.15233. Epub 2024 Oct 4. Ann N Y Acad Sci. 2024. PMID: 39365995 Free PMC article. Review.
422 results